Tumor Infiltrating Lymphocyte Therapy Combined With PD-1/LAG-3 Inhibition in Patients With Recurrent Platinum-Resistant Ovarian Cancer. - Monberg TJ; Lorentzen CL; Westergaard MCW; Iversen TZ; Borch TH; Donia M; Mannering SM; Banke SEW; Met Ö; Svane IM (International journal of cancer, 2026)